Italia markets closed

BMY Sep 2024 45.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
2,2800-0,0400 (-1,72%)
Alla chiusura: 03:07PM EDT
Schermo intero
Chiusura precedente2,3200
Aperto2,4400
Denaro2,3000
Lettera2,3500
Prezzo d'esercizio45,00
Scadenza2024-09-20
Min-Max giorno2,2800 - 2,5700
Contratto - Min-MaxN/D
Volume33
Open Interest672
  • GlobeNewswire

    Arbutus Appoints Two New Executives

    Karen Sims, MD, PhD Promoted to Chief Medical Officer Christopher Naftzger Appointed as General Counsel and Chief Compliance Officer WARMINSTER, Pa., July 10, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced the appointment of Dr. Karen Sims as Chief Medical Officer and Mr. Chri